JUNIOR STRENGTH ADVIL (ibuprofen) by GSK is cyclooxygenase inhibitors [moa]. First approved in 1996.
Drug data last refreshed Yesterday
Junior Strength Advil is an oral ibuprofen tablet formulation designed for pediatric pain and fever management. It works by inhibiting cyclooxygenase enzymes to reduce inflammation, pain, and fever across multiple indications including headache, sore throat pain, and postoperative discomfort. This nonsteroidal anti-inflammatory drug (NSAID) represents a foundational OTC/pediatric pain management option.
As a mature OTC product approaching loss of exclusivity with moderate competitive pressure (30/100), teams are focused on lifecycle management and brand loyalty in a crowded generic market.
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Effect of Extracorporeal Radial Shock Wave Ibuprofen Phonophoresis on Subacromial Space in Patients With Impingement Syndrome.
A Comparative Bioavailability Study of Reformulated Ibuprofen 2% and 4% Oral Suspensions (Berlin Chemie AG) and Versus Ibuprofen (Nurofen®) 200 mg/5 ml Oral Suspension
Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain
Efficacy and Safety of S (+) - Ibuprofen in the Treatment of Mechanical Low Back Pain
Postoperative Analgesic Effects of Ibuprofen Versus Ketorolac in Patients Undergoing in Orthopedic Surgery
Worked on JUNIOR STRENGTH ADVIL at GSK? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on Junior Strength Advil represents a mature-product career opportunity focused on defensive strategy, cost management, and market share preservation in an increasingly generic OTC landscape. Roles are concentrated in commercial and market access functions rather than innovation-driven discovery, making this suitable for professionals seeking stability and process-oriented challenges over high-growth potential.